Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,519 | -4,287 | -2,849 | -1,980 | -6,022 |
| Depreciation Amortization | 240 | 199 | 141 | 65 | 254 |
| Accounts receivable | -157 | -4 | -14 | -1 | -6 |
| Other Working Capital | -385 | -86 | 1,291 | 770 | 1,424 |
| Other Operating Activity | 21 | -237 | -571 | 20 | 515 |
| Operating Cash Flow | $-5,800 | $-4,414 | $-2,002 | $-1,126 | $-3,835 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 31 | 19 | 19 | -9 | -13 |
| Investing Cash Flow | $31 | $19 | $19 | $-9 | $-13 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 100 | 133 | 199 | 53 | 80 |
| Debt Issued | 1,000 | 1,000 | 1,000 | N/A | N/A |
| Common Stock Issued | 6,470 | 3,000 | 1,500 | N/A | 4,511 |
| Other Financing Activity | -2,666 | -179 | -62 | -26 | -52 |
| Financing Cash Flow | $4,904 | $3,954 | $2,637 | $27 | $4,539 |
| Beginning Cash Position | 1,166 | 1,166 | 1,166 | 1,166 | 476 |
| End Cash Position | 302 | 725 | 1,820 | 58 | 1,166 |
| Net Cash Flow | $-864 | $-441 | $654 | $-1,108 | $690 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,800 | -4,414 | -2,002 | -1,126 | -3,835 |
| Capital Expenditure | -9 | -9 | -9 | -9 | -55 |
| Free Cash Flow | -5,809 | -4,423 | -2,011 | -1,135 | -3,891 |